Nanocapsules of oxalate oxidase for hyperoxaluria treatment

Phosphorylcholine polymer nanocapsules prolong the circulation time and reduce the immunogenicity of therapeutic proteins

(2016) Sheng Liang et al.   Nano Research

Enzyme therapeutics for systemic detoxification

(2015) Yang Liu et al.   ADVANCED DRUG DELIVERY REVIEWS

Robust enzyme–silica composites made from enzyme nanocapsules

(2015) Jie Li et al.   CHEMICAL COMMUNICATIONS

Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity

(2015) Peng Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans

(2015) Hong Zhang et al.   VACCINE

Zwitterionic drug nanocarriers: A biomimetic strategy for drug delivery

(2014) Qiao Jin et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts

(2014) Georgios Karaolanis et al.   Transplantation Reviews

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

(2013) P. L. Rodriguez et al.   SCIENCE

Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions

(2012) Bodo B Beck et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake

(2011) Carl D. Walkey et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity

(2011) Andrew J. Keefe et al.   Nature Chemistry

The primary hyperoxalurias

(2009) Bernd Hoppe et al.   KIDNEY INTERNATIONAL